Mice transplanted with cells expressing the control shRNA succumbed to AML an average of 10 days post-transplant whereas cells expressing an shRNA targeting ETFA and ETFB led to mice living significantly longer (Fig. 6E). This evidence concerns the gene ETFA and acute myeloid leukemia.